Beneficial results have been seen during a trial a novel drug for treatment-resistant and refractory multiple myeloma.
In the phase 1/2 study, the drug mezigdomide is given orally alongside the steroid dexamethasone. The study has shown mezigdomid...
1 year ago
Autologous stem cell treatment is effective in slowing progression of multiple sclerosis, according to a new Swedish study into its use in routine healthcare.
There is growing evidence that autologous haematopoietic stem cell transplantation (aHSC...
1 year ago
